Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Kardium Inc.
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
A diagnosis of recurrent symptomatic paroxysmal or persistent AF
Failure or intolerance of at least one antiarrhythmic drug (AAD) Class I or III or AAD naïve subjects
You may not be if
Long-standing persistent AF (sustained \>12 months)
Atrial fibrillation secondary to a reversible cause or of non-cardiac origin
History of thromboembolic events within the past six months
Myocardial infarction (MI)/percutaneous coronary intervention (PCI) within the last three months
Any cardiac surgery within the previous six months
Prior left atrial ablation or surgical procedure
Presence of an implanted cardiac device
Body mass index (BMI) \>40 kg/m\^2
Left ventricular ejection fraction (LVEF) \<35%
Anterior-posterior left atrial (LA) diameter \>55mm
Right atrial minor-axis (transverse) diameter \<32mm for adjunctive cavotricuspid isthmus (CTI) ablation only
Clareo Health | Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation
